Glaukos Corp Stock Performance
| GKOS Stock | USD 115.55 0.66 0.57% |
On a scale of 0 to 100, Glaukos Corp holds a performance score of 15. The company retains a Market Volatility (i.e., Beta) of 0.99, which attests to possible diversification benefits within a given portfolio. Glaukos Corp returns are very sensitive to returns on the market. As the market goes up or down, Glaukos Corp is expected to follow. Please check Glaukos Corp's coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Glaukos Corp's current trending patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Glaukos Corp are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Glaukos Corp unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.57) | Five Day Return (0.71) | Year To Date Return (22.80) | Ten Year Return 361.65 | All Time Return 270.12 |
1 | Glaukos Wins FDA Nod for EpioxaIs a New Era in Keratoconus Care Taking Shape | 10/21/2025 |
2 | Glaukos price target raised by 10 at JPMorgan, heres why GKOS | 10/30/2025 |
3 | Primecap Management Co. CA Acquires 609,523 Shares of Glaukos Corporation GKOS | 11/20/2025 |
4 | Disposition of 315 shares by Alex Thurman of Glaukos Corp at 105.0 subject to Rule 16b-3 | 11/25/2025 |
5 | Why Glaukos Is Up 13.9 percent After iDose Tops Forecasts and 2025 Outlook Rises | 11/26/2025 |
6 | Is Glaukos Corporation stock a top hedge fund pick - July 2025 Price Swings Reliable Breakout Stock Forecasts - Newser | 12/01/2025 |
7 | Inogen Down 0.6 percent Since Last Earnings Report Can It Rebound | 12/05/2025 |
8 | Disposition of 5000 shares by Gilbert Kliman of Glaukos Corp at 24.69 subject to Rule 16b-3 | 12/09/2025 |
9 | Glaukos Announces Participation in J.P. Morgan Healthcare Conference | 12/16/2025 |
| Begin Period Cash Flow | 93.5 M | |
| Total Cashflows From Investing Activities | 47.8 M |
Glaukos Corp Relative Risk vs. Return Landscape
If you would invest 8,155 in Glaukos Corp on September 30, 2025 and sell it today you would earn a total of 3,400 from holding Glaukos Corp or generate 41.69% return on investment over 90 days. Glaukos Corp is currently generating 0.5997% in daily expected returns and assumes 3.0569% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than Glaukos, and 88% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Glaukos Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Glaukos Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Glaukos Corp, and traders can use it to determine the average amount a Glaukos Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1962
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GKOS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Glaukos Corp is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Glaukos Corp by adding it to a well-diversified portfolio.
Glaukos Corp Fundamentals Growth
Glaukos Stock prices reflect investors' perceptions of the future prospects and financial health of Glaukos Corp, and Glaukos Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Glaukos Stock performance.
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0574 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 6.51 B | ||||
| Shares Outstanding | 57.43 M | ||||
| Price To Earning | 94.70 X | ||||
| Price To Book | 8.67 X | ||||
| Price To Sales | 14.21 X | ||||
| Revenue | 383.48 M | ||||
| Gross Profit | 361.14 M | ||||
| EBITDA | (95.64 M) | ||||
| Net Income | (146.37 M) | ||||
| Cash And Equivalents | 391.19 M | ||||
| Cash Per Share | 8.22 X | ||||
| Total Debt | 105.87 M | ||||
| Debt To Equity | 0.68 % | ||||
| Current Ratio | 6.78 X | ||||
| Book Value Per Share | 13.41 X | ||||
| Cash Flow From Operations | (61.32 M) | ||||
| Earnings Per Share | (1.55) X | ||||
| Market Capitalization | 6.67 B | ||||
| Total Asset | 974.76 M | ||||
| Retained Earnings | (745.44 M) | ||||
| Working Capital | 374.67 M | ||||
| Current Asset | 104.14 M | ||||
| Current Liabilities | 20.36 M | ||||
About Glaukos Corp Performance
Assessing Glaukos Corp's fundamental ratios provides investors with valuable insights into Glaukos Corp's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Glaukos Corp is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 223.90 | 148.73 | |
| Return On Tangible Assets | (0.23) | (0.24) | |
| Return On Capital Employed | (0.14) | (0.14) | |
| Return On Assets | (0.15) | (0.16) | |
| Return On Equity | (0.19) | (0.18) |
Things to note about Glaukos Corp performance evaluation
Checking the ongoing alerts about Glaukos Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Glaukos Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Glaukos Corp appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 383.48 M. Net Loss for the year was (146.37 M) with profit before overhead, payroll, taxes, and interest of 361.14 M. | |
| Glaukos Corp currently holds about 391.19 M in cash with (61.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22. | |
| Glaukos Corp has a frail financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Glaukos Announces Participation in J.P. Morgan Healthcare Conference |
- Analyzing Glaukos Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Glaukos Corp's stock is overvalued or undervalued compared to its peers.
- Examining Glaukos Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Glaukos Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Glaukos Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Glaukos Corp's stock. These opinions can provide insight into Glaukos Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.